Aurélien Traversier

International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada)

Université de Lyon - Université Claude Bernard Lyon 1

Centre International de Recherche en Infectiologie (CIRI) - Team VirPath, Univ Lyon, 14 Inserm, U1111

France

Université de Lyon - VirNext, Faculté de Médecine RTH Laennec

France

  • Centre International de Recherche en Infectiologie (CIRI) - Team VirPath, Univ Lyon, 14 Inserm, U1111

  • Université de Lyon - VirNext, Faculté de Médecine RTH Laennec

SCHOLARLY PAPERS

4

DOWNLOADS

116

TOTAL CITATIONS

0

Scholarly Papers (4)

Actions:
Email selected abstracts
1.

Host-Directed Repurposed Diltiazem Enhances the Antiviral Activity of Classic Antivirals Against Influenza and Sars-Cov-2

Number of pages: 36 Posted: 10 Dec 2024
Blandine Padey, Clément Droillard, Victoria Dulière, Julien Fouret, Claire Nicolas de Lamballerie, Cédrine Milesi, Emilie Laurent, Pauline Brun, Aurélien Traversier, Thomas Julien, Olivier Terrier, Manuel Rosa-Calatrava and Andrés Pizzorno
affiliation not provided to SSRN, International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), Université de Lyon - Université Claude Bernard Lyon 1, International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada) and International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada)
Downloads 40 (856,953)

Abstract:

Loading...

diltiazem, host-directed antivirals, drug combination, Respiratory Viruses, Influenza, SARS-COV-2

2.

New Mucosal Bivalent Live-Attenuated Vaccine is Protective Against Human Metapneumovirus and Respiratory Syncytial Virus

Number of pages: 48 Posted: 06 Jul 2023
Daniela Ogonczyk-Makowska, Clémence Vacher, Andrés Pizzorno, Pauline Brun, Caroline Chupin, Clément Droillard, Julie Carbonneau, Emilie Laurent, Victoria Duliere, Aurélien Traversier, Olivier Terrier, Thomas Julien, Marie Galloux, Stephane Paul, Jean-Francois Eleouet, Marie-Ève Hamelin, Guy Boivin, Manuel Rosa-Calatrava and Julia Dubois
Centre de Recherche en Infectiologie of the Centre Hospitalier Universitaire de Québec and Université Laval, Centre de Recherche en Infectiologie of the Centre Hospitalier Universitaire de Québec and Université Laval, International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), Université Laval- Infectious Disease Research Centre, International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), Université de Lyon - Université Claude Bernard Lyon 1, University of Paris-Saclay - UVSQ, VIM, University of Claude Bernard Lyon 1 - CIRI, University of Paris-Saclay - UVSQ, VIM, Université Laval- Infectious Disease Research Centre, Centre de Recherche en Infectiologie of the Centre Hospitalier Universitaire de Québec and Université Laval, International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada) and International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada)
Downloads 33 (917,911)

Abstract:

Loading...

RSV, HMPV, chimeric virus, bivalent vaccine, live attenuated vaccine, vectored vaccine, reverse genetics, gene insertion, respiratory viruses, pneumovirus, bronchiolitis

3.

Impaired Mucosal IgA Response in Patients with Severe COVID-19

Number of pages: 30 Posted: 23 Apr 2024
Melyssa Yaugel-Novoa, Blandine Noailly, Fabienne Jospin, Andrés Pizzorno, Aurélien Traversier, Bruno Pozzetto, Louis Waeckel, Stephanie Longet, Sylvie Pillet, Elisabeth Botelho-Nevers, Manuel Rosa-Calatrava, Thomas Bourlet and Stephane Paul
University of Saint Etienne - Centre Hospitalier Universitaire de Saint-Étienne, University of Saint Etienne - Centre Hospitalier Universitaire de Saint-Étienne, University of Saint Etienne - Centre Hospitalier Universitaire de Saint-Étienne, International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), University of Saint Etienne - Centre Hospitalier Universitaire de Saint-Étienne, University of Saint Etienne - Centre Hospitalier Universitaire de Saint-Étienne, University of Saint Etienne - Centre Hospitalier Universitaire de Saint-Étienne, University of Saint Etienne - Centre Hospitalier Universitaire de Saint-Étienne, University of Saint Etienne - Centre Hospitalier Universitaire de Saint-Étienne, International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), University of Saint Etienne - Centre Hospitalier Universitaire de Saint-Étienne and University of Claude Bernard Lyon 1 - CIRI
Downloads 32 (927,110)

Abstract:

Loading...

IgA, COVID-19, severity, lung, polyfunctionality

4.

A Combinatorial and Computational Tandem Approach Towards a Universal Therapeutics Against Ace2-Mediated Coronavirus Infections

Number of pages: 40 Posted: 18 Sep 2024
Chia Yin Lee, Ching-Wen Huang, Louis De Falco Jr, Rabi atul Adawiyah Binte Minhat, Aurélien Traversier, Bei Wang, Siti Nazihah Mohd Salleh, Eve Ngoh, Yuling Huang, Jenna Kim, Matthew Zirui Tay, Manuel Rosa-Calatrava, Andrés Pizzorno, Roland G. Huber, Cheng-I Wang and Sneak Peek Administrator
Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR) - Infectious Diseases Horizontal Technology Centre, Agency for Science, Technology and Research (A*STAR) - A*STAR Infectious Diseases Labs, International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), Agency for Science, Technology and Research (A*STAR) - Biomolecular Function Discovery, Agency for Science, Technology and Research (A*STAR) - Singapore Immunology Network (SIgN) and Independent
Downloads 11 (1,166,248)

Abstract:

Loading...